Template:Non pregnant vaginal bleeding treatment: Difference between revisions
Ostermayer (talk | contribs) (Created page with "*Iron supplementation *Ibuprofen **For cramps and can theoretically decreases intra-uterine bleeding *Hormonal Therapy: *'''Medroxyprogesterone''' **Give only if endocervi...") |
Ostermayer (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
===Mild Bleeding=== | |||
*Iron supplementation | *Iron supplementation | ||
*[[Ibuprofen]] | *[[Ibuprofen]] | ||
**For cramps and can theoretically decreases intra-uterine bleeding | **For cramps and can theoretically decreases intra-uterine bleeding | ||
===Moderate continued bleeding== | |||
*Hormonal Therapy: | *Hormonal Therapy: | ||
*'''Medroxyprogesterone''' | *'''Medroxyprogesterone''' | ||
Revision as of 00:44, 7 June 2016
Mild Bleeding
- Iron supplementation
- Ibuprofen
- For cramps and can theoretically decreases intra-uterine bleeding
=Moderate continued bleeding
- Hormonal Therapy:
- Medroxyprogesterone
- Give only if endocervical curettage/endometrial biopsy does not need to be performed (young patient) or has already been performed, as they may alter test results
- 150mg IM x 1 then 20mg PO Q8hrs x 3 days
- In a trial of 48 patients all had cessation in 5 days.[1]
Life Threatening
- Establish large bore IV access
- Prepare for emergent blood transfusion uncrossmatched O-negative blood if typed blood is not available.
- It is possible to temporize bleeding w/ intravaginal packing with kerlix soaked in with thrombin
- If bleeding is due to a traumatic cause emergent surgical repair is necessary
- Tranexamic acid [2]
- Coordinate with OBGYN prior to administration due to the increased thrombotic risk
- Acutely 10 mg/kg IV, max dose of 600 mg[3]
- Then 1-1.5 g TID PO for 5 days
- ↑ Ammerman SR, Nelson AL. A new progestogen-only medical therapy for outpatient management of acute, abnormal uterine bleeding: a pilot study. Am J Obstet Gynecol. 2013. 208(6):499.e1-e5.
- ↑ Leminen and Hurskainen. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety. Int J Womens Health. 2012; 4: 413–421.
- ↑ Committee on Gynecological Practice. Management of Acute Abnormal Uterine Bleeding in Nonpregnant Reproductive-Aged Women. April 2013. http://www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Gynecologic-Practice/Management-of-Acute-Abnormal-Uterine-Bleeding-in-Nonpregnant-Reproductive-Aged-Women